Life Sciences
The biotechnology company told MobiHealthNews it will continue to work within the digital health space through partnerships linked to its 'evolving R&D and commercial priorities.'
The Japanese manufacturer's new company, established in Delaware, will utilize a cell picking and imaging system to help providers detect and treat diseases.
Behavioral health company Owl partners with Medicaid plan Colorado Access, and hybrid care platform Amwell integrates Health Gorilla's lab offerings into its platform.
The company will use the funds to enrich its technology, commercialize its MRD product and continue the development of its multi-cancer early detection offering.
The partnership grew out of a philosophical alignment between the companies, with each citing the desire to simplify access and pricing.
Postmenopausal patients can get a prescription for ASCEND Therapeutics' EstroGel by scheduling an appointment with a LifeMD provider through the pharma brand's website.
Data exchange platform Briya and clinical trial-participant management platform Mural Health also secured investments.
The funds will be used to develop AI-enabled ultrasound technology for maternal care and pediatric lung health in low- and middle-income countries.
Medicare-focused virtual exercise platform Bold secured $17 million.
The pair will work to further the practice of radiology and patient care using innovation, such as theranostics, AI and digital health platforms.